Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 3/20 | 0.31 |
| ▸ | CA9 | Q16790 | 3/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12069014 | 1.00 | SCN9A (0.34) | SCN9ACA2CA1ITGB3ITGA2B | |
| SCHEMBL12071190 | 1.00 | SCN9A (0.34) | SCN9ACA2CA1ITGB3ITGA2B | |
| SCHEMBL16478583 | 0.84 | USP2 (0.33) | CA2CA1ITGB3ITGA2BUSP2 | |
| SCHEMBL21389077 | 0.83 | CA1 (0.35) | SCN9ACA2CA1ITGB3ITGA2B | |
| SCHEMBL21389092 | 0.83 | CA1 (0.35) | SCN9ACA2CA1ITGB3ITGA2B | |
| SCHEMBL157579 | 0.83 | CA1 (0.33) | CA2CA1CA12CA9CA14 | |
| SCHEMBL7357154 | 0.81 | ECE1 (0.40) | SCN9ACA2CA1ITGB3ITGA2B | |
| SCHEMBL7357150 | 0.81 | ECE1 (0.40) | SCN9ACA2CA1ITGB3ITGA2B | |
| SCHEMBL16886886 | 0.81 | ECE1 (0.40) | SCN9ACA2CA1ITGB3ITGA2B | |
| SCHEMBL24108521 | 0.80 | ITGB3 (0.39) | ITGB3ITGA2BUSP2TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4531566-A1 | AZOLE FUNGICIDE COMPOSITION | ADAMA MAKHTESHIM LTD. (IL) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023233378-A1 | AZOLE FUNGICIDE COMPOSITION | ADAMA MAKHTESHIM LTD. (IL) | 2023-12-07 | — | — | WO | disclosed |
| EP-4255190-A1 | COPPER-BASED FUNGICIDE COMPOSITION | ADAMA MAKHTESHIM LTD. (IL) | 2023-10-11 | — | — | EP | disclosed |
| WO-2022118255-A1 | COPPER-BASED FUNGICIDE COMPOSITION | ADAMA MAKHTESHIM LTD. (IL) | 2022-06-09 | — | — | WO | disclosed |
| WO-2020226482-A1 | SYNERGISTIC COMPOSITIONS FOR CONTROLLING PLANT PATHOGENS WITH CHITINOLYTIC MICROORGANISMS / ORGANIC ACID COMBINATIONS AND METHOD OF USE THEREOF | LAI HONG HENG (MY) | 2020-11-12 | — | — | WO | disclosed |
| US-20160326111-A1 | ARYL SUBSTITUTED INDOLES AND THE USE THEREOF | PURDUE PHARMA LP (US) | 2016-11-10 | — | — | US | disclosed |
| US-9212139-B2 | Aryl substituted indoles and their use as blockers of sodium channels | PURDUE PHARMA, L.P. (US) | 2015-12-15 | — | — | US | disclosed |
| EP-2809157-A2 | FUNGICIDAL PYRAZOLE MIXTURES | E. I. Du Pont de Nemours and Company (US) | 2014-12-10 | — | — | EP | disclosed |
| EP-2582666-B1 | ARYL SUBSTITUTED INDOLES AND THEIR USE AS BLOCKERS OF SODIUM CHANNELS | PURDUE PHARMA LP (US) | 2014-08-13 | — | — | EP | disclosed |
| US-20130296281-A1 | Aryl Substituted Indoles and Their Use as Blockers of Sodium Channels | PURDUE PHARMA L.P. (US) | 2013-11-07 | — | — | US | disclosed |
| WO-2013116251-A2 | FUNGICIDAL PYRAZOLE MIXTURES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-08-08 | — | — | WO | disclosed |
| EP-1667525-B1 | CONCENTRATED SUSPENSIONS | BAYER CROPSCIENCE AG (DE) | 2012-12-19 | — | — | EP | disclosed |
| CN-101006056-B | 3' -alkoxy spirocyclic tetramic and tetronic acids | BAYER CROPSCIENCE AG | 2012-07-25 | — | — | CN | disclosed |
| EP-2403834-A1 | Fungicidal pyrazoles | E. I. du Pont de Nemours and Company (US) | 2012-01-11 | — | — | EP | disclosed |
| WO-2011158108-A2 | ARYL SUBSTITUTED INDOLES AND THE USE THEREOF | PURDUE PHARMA L.P. (US) | 2011-12-22 | — | — | WO | disclosed |
| WO-2010101973-A1 | FUNGICIDAL PYRAZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-10 | — | — | WO | disclosed |
| CN-101495448-A | alkoxyalkyl-substituted cyclic ketoenols | BAYER CROPSCIENCE AG (DE) | 2009-07-29 | — | — | CN | disclosed |
| EP-1558592-A1 | THIAZOL-(BI)CYCLOALKYL-CARBOXANILIDES | Bayer CropScience Aktiengesellschaft (DE) | 2005-08-03 | — | — | EP | disclosed |
| WO-2004039789-A1 | THIAZOL-(BI)CYCLOALKYL-CARBOXANILIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-05-13 | — | — | WO | disclosed |
| EP-0259092-A1 | Substituted hexahydroarylquinolizines | MERCK & CO. INC. (US) | 1988-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296281-A1 | Aryl Substituted Indoles and Their Use as Blockers of Sodium Channels | SCN5A, TRPV1, TRPV5 | SCN9A 75/4885CA2 342/4885CA1 1691/4885 |
| US-20160326111-A1 | ARYL SUBSTITUTED INDOLES AND THE USE THEREOF | TRPC5, TRPV5, TRPV1 | SCN9A 110/4885CA2 382/4885CA1 1362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.